Atrial fibrillation is a serious condition with a strongly elevated risk of death, heart failure, and stroke, as demonstrated in large-scale cohort research. Blood thinners are the best-supported means of preventing stroke; lifestyle changes are a valuable addition but have been less thoroughly studied over the long term. Treatment requires a tailored approach and guidance from a physician.
Atrial fibrillation, also known as AFib, is a heart rhythm disorder in which the atria beat chaotically rather than in an orderly fashion. Large observational research involving nearly 9.7 million people shows that people with atrial fibrillation have a 46% higher chance of dying than people without this condition. That is not a small difference, and it justifies doctors taking this condition seriously.
The greatest concrete danger is heart failure: the risk of this is almost five times higher in atrial fibrillation than in people with a normal heart rhythm. The risk of a stroke caused by a blood clot is also more than doubled. Women face an even greater stroke risk than men with the same condition, and they die from a stroke or suffer a recurrent stroke more often. In addition, atrial fibrillation is associated with a 64% higher risk of chronic kidney disease. In people who also have diabetes, there is additional evidence from one large Korean cohort study that the risk of a foot amputation increases more than fourfold, although this is a striking finding that still requires confirmation.
One type of stroke, hemorrhagic stroke (bleeding in the brain), does not appear to occur significantly more often in atrial fibrillation: the available data showed too much statistical uncertainty here to allow a reliable conclusion.
The most proven way to prevent stroke in atrial fibrillation is the use of blood thinners (anticoagulants). Modern agents that do not work via vitamin K are included among these. The choice of the right drug and the dosage is determined individually based on a person's risk profile, because blood thinners themselves also increase the risk of bleeding. This is a decision that the treating physician carefully discusses with the patient.
In addition to medication, there is reasonable evidence that lifestyle changes can reduce the burden of atrial fibrillation: losing weight if overweight, exercising more, drinking less alcohol, quitting smoking, getting sleep apnea treated, and keeping blood pressure well controlled. This approach is seen as a fourth pillar alongside the standard drug treatments. Long-term randomized studies to map this effect precisely are still scarce, but the underlying approach aligns with broader, generally accepted advice for cardiovascular health. Finally, atrial fibrillation is also the most common complication after heart surgery; patients undergoing a cardiac procedure can specifically ask their doctor about the prevention and treatment of this risk.
All claims are based on observational cohort studies and a large meta-analysis (PMID 27599725, ~9.7 million participants). The associations are associative, not formally proven to be causal, but the magnitude and consistency are substantial. The claim about blood thinners is supported by guideline literature and clinical studies (PMID 29028452, 33846159, 20031792). Lifestyle evidence is more limited (PMID 36598428). The finding on foot amputation in diabetes + atrial fibrillation comes from one study (PMID 37851370) and requires confirmation.